RESUMEN
Higgsinos with masses near the electroweak scale can solve the hierarchy problem and provide a dark matter candidate, while detecting them at the LHC remains challenging if their mass splitting is O(1 GeV). This Letter presents a novel search for nearly mass-degenerate Higgsinos in events with an energetic jet, missing transverse momentum, and a low-momentum track with a significant transverse impact parameter using 140 fb^{-1} of proton-proton collision data at sqrt[s]=13 TeV collected by the ATLAS experiment. For the first time since LEP, a range of mass splittings between the lightest charged and neutral Higgsinos from 0.3 to 0.9 GeV is excluded at 95% confidence level, with a maximum reach of approximately 170 GeV in the Higgsino mass.
RESUMEN
INTRODUCTION AND OBJECTIVES: Some studies investigating the effect of calcium on neostigmine-induced recovery of neuromuscular blockade have shown that this combination promotes neuromuscular recovery, but does not significantly affect the incidence of postoperative residual curarization and time to extubation. This study aimed to evaluate the effects of 10â¯mg/kg calcium chloride co-administered with neostigmine on early recovery and time to extubation. PATIENTS AND METHODS: This prospective, randomized, double-blinded, placebo-controlled study included 88 ASA I-II patients aged between 18 and 65 years who were scheduled for elective surgery lasting at least 1â¯h under general anaesthesia in which 10â¯mg/kg of calcium chloride or the same volume of normal saline was co-administered with 5⯵g/kg of neostigmine at the end of surgery. Time to extubation (time from neostigmine administration to extubation), time from neostigmine administration to TOF ratio (TOFr) 0.9 (neuromuscular recovery), and the incidence of residual neuromuscular blockade (RNMB) and other adverse effects were recorded. RESULTS: Median (Q1, Q3) extubation time was significantly shorter in the calcium group vs. the placebo group (6.5â¯min [5.52-7.43] vs. 9.78â¯min [8.35-11]), Pâ¯<â¯.001. Median neuromuscular recovery time in the calcium group was 5â¯min vs. 7.1â¯min in the placebo group, Pâ¯<â¯.001. Patients in the calcium group had significantly higher TOFr and lower incidence of RNMB at 5 and 10â¯min vs. the placebo group, and no significant side effects. CONCLUSION: Calcium chloride at a dose of 10â¯mg/kg co-administered with neostigmine promotes early neuromuscular recovery and reduces time to extubation by about 32%.